---
title: Chlordiazepoxide + Imipramine
description: >-
  Chlordiazepoxide + Imipramine is prescribed for the treatment of moderate to
  severe depression and anxiety disorders.  This combination medication falls
  under the pharmacological classifications of benzodiazepine (chlordiazepoxide)
  and tricyclic antidepressant (imipramine).  Chlordiazepoxide enha...
is_banned: false
lastModified: '2025-09-22T17:22:08.661Z'
faqs:
  - q: >-
      What is the recommended dosage for Chlordiazepoxide + Imipramine?**


      **A:**  The initial dose is typically Chlordiazepoxide 5-10mg and
      Imipramine 25 mg three to four times a day. It can be adjusted based on
      the patient's response, up to a maximum of Chlordiazepoxide 25mg and
      Imipramine 150 mg per day for outpatients. Higher doses may be used in
      hospitalized patients under close monitoring.
    a: >-
      A:**  The initial dose is typically Chlordiazepoxide 5-10mg and Imipramine
      25 mg three to four times a day. It can be adjusted based on the patient's
      response, up to a maximum of Chlordiazepoxide 25mg and Imipramine 150 mg
      per day for outpatients. Higher doses may be used in hospitalized patients
      under close monitoring.
  - q: >-
      What are the most common side effects?**


      **A:**  Common side effects include drowsiness, dry mouth, constipation,
      blurred vision, urinary retention, and orthostatic hypotension.
    a: >-
      A:**  Common side effects include drowsiness, dry mouth, constipation,
      blurred vision, urinary retention, and orthostatic hypotension.
  - q: >-
      What are the serious side effects that require immediate attention?**


      **A:** Cardiac arrhythmias, seizures, severe allergic reactions, and
      neuroleptic malignant syndrome require immediate medical intervention.
    a: >-
      A:** Cardiac arrhythmias, seizures, severe allergic reactions, and
      neuroleptic malignant syndrome require immediate medical intervention.
  - q: >-
      Can Chlordiazepoxide + Imipramine be used during pregnancy?**


      **A:**  Generally, it is avoided during pregnancy due to potential risks
      to the fetus. If considered necessary, a careful risk-benefit assessment
      should be conducted.
    a: >-
      A:**  Generally, it is avoided during pregnancy due to potential risks to
      the fetus. If considered necessary, a careful risk-benefit assessment
      should be conducted.
  - q: >-
      How does Chlordiazepoxide + Imipramine interact with alcohol?**


      **A:** Combining this medication with alcohol can potentiate the sedative
      effects, leading to increased drowsiness and impaired coordination. It is
      advisable to avoid alcohol consumption during treatment.
    a: >-
      A:** Combining this medication with alcohol can potentiate the sedative
      effects, leading to increased drowsiness and impaired coordination. It is
      advisable to avoid alcohol consumption during treatment.
  - q: >-
      What should be done if a patient experiences severe side effects?**


      **A:** Discontinue the medication immediately and seek urgent medical
      attention.
    a: >-
      A:** Discontinue the medication immediately and seek urgent medical
      attention.
  - q: >-
      Can Chlordiazepoxide + Imipramine be used in patients with liver
      disease?**


      **A:**  Use with caution in patients with liver disease due to the risk of
      impaired metabolism. Dosage adjustments may be necessary. Close monitoring
      of liver function is essential.
    a: >-
      A:**  Use with caution in patients with liver disease due to the risk of
      impaired metabolism. Dosage adjustments may be necessary. Close monitoring
      of liver function is essential.
  - q: >-
      What are the key drug interactions to be aware of?**


      **A:** Significant interactions can occur with CNS depressants (alcohol,
      opioids), MAOIs, CYP2D6 and CYP3A4 inhibitors/inducers, and other
      serotonergic drugs.
    a: >-
      A:** Significant interactions can occur with CNS depressants (alcohol,
      opioids), MAOIs, CYP2D6 and CYP3A4 inhibitors/inducers, and other
      serotonergic drugs.
  - q: >-
      Are there any specific monitoring parameters for patients on
      Chlordiazepoxide + Imipramine?**


      **A:**  Monitoring should include blood pressure, heart rate, liver
      function tests, complete blood count, and mental status assessment.
    a: >-
      A:**  Monitoring should include blood pressure, heart rate, liver function
      tests, complete blood count, and mental status assessment.
  - q: >-
      What are the long-term risks associated with Chlordiazepoxide + Imipramine
      use?**


      **A:**  Long-term risks may include tardive dyskinesia (with prolonged
      imipramine use) and tolerance to the sedative effects of chlordiazepoxide.
      Regular monitoring and periodic reevaluation of treatment are important.
    a: >-
      A:**  Long-term risks may include tardive dyskinesia (with prolonged
      imipramine use) and tolerance to the sedative effects of chlordiazepoxide.
      Regular monitoring and periodic reevaluation of treatment are important.
---
## **Usage**

Chlordiazepoxide + Imipramine is prescribed for the treatment of moderate to severe depression and anxiety disorders.  This combination medication falls under the pharmacological classifications of benzodiazepine (chlordiazepoxide) and tricyclic antidepressant (imipramine).  Chlordiazepoxide enhances the effect of the inhibitory neurotransmitter GABA, leading to a calming effect. Imipramine works by inhibiting the reuptake of serotonin and norepinephrine, thereby increasing their levels in the brain.

## **Alternate Names**

While the generic name is Chlordiazepoxide + Imipramine, it is marketed under various brand names, including Limbitrol and Depixol.

## **How It Works**

**Pharmacodynamics:** Chlordiazepoxide acts on GABA receptors, leading to neuronal inhibition and reduced anxiety. Imipramine inhibits the reuptake of serotonin and norepinephrine, resulting in elevated mood and decreased depression symptoms.

**Pharmacokinetics:** Both drugs are absorbed orally. Chlordiazepoxide is metabolized in the liver, primarily by CYP3A4, and excreted renally. Imipramine is extensively metabolized in the liver, mainly by CYP2D6 and CYP2C19, to its active metabolite, desipramine. Both drugs and their metabolites are excreted primarily in the urine.

**Mode of Action:** Chlordiazepoxide potentiates the effects of GABA by binding to the benzodiazepine site on the GABA<sub>A</sub> receptor. Imipramine blocks the presynaptic reuptake transporters for serotonin and norepinephrine.

**Elimination Pathways:** Chlordiazepoxide is primarily eliminated via hepatic metabolism and renal excretion. Imipramine is eliminated through hepatic metabolism (CYP2D6 and CYP2C19) and renal excretion.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

Initial dosage is usually Chlordiazepoxide 5-10mg and Imipramine 25mg, 3-4 times a day. This can be gradually increased based on individual response and tolerability, up to a maximum of Chlordiazepoxide 25mg and Imipramine 150mg per day for outpatients. For hospitalized patients with severe depression, Imipramine may be increased up to 300 mg/day.

#### **Children:**

Imipramine use in children is primarily for enuresis (bedwetting). The dosage varies depending on the child's age and weight, and is typically administered once daily before bedtime. It's not recommended for children under 6 years of age. Chlordiazepoxide use is generally avoided in children under 6. For older children, dosage should start low and gradually increase if necessary.

#### **Special Cases:**

* **Elderly Patients:** Start with lower doses of both medications due to age-related decline in metabolic function and increased sensitivity. Dosage adjustments should be made cautiously and based on individual response.
* **Patients with Renal Impairment:** Reduce the dose of both medications as they are primarily renally excreted. 
* **Patients with Hepatic Dysfunction:**  Reduce the dose of both medications as they are extensively metabolized by the liver.  Careful monitoring for adverse effects is necessary.
* **Patients with Comorbid Conditions:** Dosage adjustment might be necessary in patients with comorbid conditions like diabetes or cardiovascular disease. Careful monitoring of these conditions is crucial.

### **Clinical Use Cases**

The combined use of Chlordiazepoxide and Imipramine in specific clinical settings like intubation, surgical procedures, mechanical ventilation, ICU use, and emergency situations is generally not recommended. Other medications are typically preferred in such scenarios.

### **Dosage Adjustments**

Dosage should be adjusted based on the individual patient's response and tolerance.  Consider renal and hepatic function, age, and co-existing conditions when adjusting dosages. Therapeutic drug monitoring may be helpful, especially for Imipramine and its active metabolite, desipramine.


## **Side Effects**

### **Common Side Effects:**

Drowsiness, dry mouth, constipation, blurred vision, urinary retention, orthostatic hypotension, and weight gain.

### **Rare but Serious Side Effects:**

Cardiac arrhythmias, seizures, agranulocytosis, jaundice, and neuroleptic malignant syndrome.

### **Long-Term Effects:**

Tardive dyskinesia (with prolonged imipramine use), tolerance to the sedative effects of chlordiazepoxide.

### **Adverse Drug Reactions (ADR):**

Severe allergic reactions (anaphylaxis), serotonin syndrome (if combined with other serotonergic drugs).

## **Contraindications**

Hypersensitivity to benzodiazepines or tricyclic antidepressants, acute angle-closure glaucoma, urinary retention, severe hepatic impairment, recent myocardial infarction, concurrent use of MAOIs.

## **Drug Interactions**

Alcohol, CNS depressants (barbiturates, opioids), anticholinergics, CYP2D6 and CYP3A4 inhibitors or inducers, MAOIs, antihypertensives, anticoagulants, other serotonergic drugs.


## **Pregnancy and Breastfeeding**

Chlordiazepoxide is classified as Pregnancy Category D. Imipramine is classified as Pregnancy Category C/D. These drugs should be avoided during pregnancy unless the benefits outweigh the risks.  Both drugs are excreted in breast milk and may cause adverse effects in the nursing infant. Alternative medications should be considered.

## **Drug Profile Summary**

* **Mechanism of Action:** Chlordiazepoxide enhances GABA activity; Imipramine inhibits serotonin and norepinephrine reuptake.
* **Side Effects:** Drowsiness, dry mouth, constipation, blurred vision, urinary retention, orthostatic hypotension. Serious: Cardiac arrhythmias, seizures.
* **Contraindications:** Hypersensitivity, glaucoma, urinary retention, hepatic impairment, recent MI, concurrent MAOI use.
* **Drug Interactions:** Alcohol, CNS depressants, CYP2D6/3A4 inhibitors/inducers, MAOIs.
* **Pregnancy & Breastfeeding:**  Generally avoided.
* **Dosage:**  Individualized, starting low and titrating upwards. Elderly patients require lower doses.
* **Monitoring Parameters:**  Blood pressure, heart rate, liver function tests, complete blood count, and mental status.

## **Popular Combinations**

While Chlordiazepoxide and Imipramine are combined in some formulations, combining them with other medications is generally avoided due to the increased risk of adverse effects.

## **Precautions**

* **General Precautions:** Assess for allergies, baseline organ function, and co-existing conditions.
* **Specific Populations:** Avoid in pregnancy and breastfeeding if possible. Start with lower doses in elderly and children.
* **Lifestyle Considerations:** Limit alcohol intake, avoid operating machinery, and be cautious when driving due to potential drowsiness.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Chlordiazepoxide + Imipramine?**

**A:**  The initial dose is typically Chlordiazepoxide 5-10mg and Imipramine 25 mg three to four times a day. It can be adjusted based on the patient's response, up to a maximum of Chlordiazepoxide 25mg and Imipramine 150 mg per day for outpatients. Higher doses may be used in hospitalized patients under close monitoring.

### **Q2:  What are the most common side effects?**

**A:**  Common side effects include drowsiness, dry mouth, constipation, blurred vision, urinary retention, and orthostatic hypotension.

### **Q3: What are the serious side effects that require immediate attention?**

**A:** Cardiac arrhythmias, seizures, severe allergic reactions, and neuroleptic malignant syndrome require immediate medical intervention.

### **Q4: Can Chlordiazepoxide + Imipramine be used during pregnancy?**

**A:**  Generally, it is avoided during pregnancy due to potential risks to the fetus. If considered necessary, a careful risk-benefit assessment should be conducted.

### **Q5: How does Chlordiazepoxide + Imipramine interact with alcohol?**

**A:** Combining this medication with alcohol can potentiate the sedative effects, leading to increased drowsiness and impaired coordination. It is advisable to avoid alcohol consumption during treatment.

### **Q6: What should be done if a patient experiences severe side effects?**

**A:** Discontinue the medication immediately and seek urgent medical attention.

### **Q7: Can Chlordiazepoxide + Imipramine be used in patients with liver disease?**

**A:**  Use with caution in patients with liver disease due to the risk of impaired metabolism. Dosage adjustments may be necessary. Close monitoring of liver function is essential.

### **Q8: What are the key drug interactions to be aware of?**

**A:** Significant interactions can occur with CNS depressants (alcohol, opioids), MAOIs, CYP2D6 and CYP3A4 inhibitors/inducers, and other serotonergic drugs.

### **Q9: Are there any specific monitoring parameters for patients on Chlordiazepoxide + Imipramine?**

**A:**  Monitoring should include blood pressure, heart rate, liver function tests, complete blood count, and mental status assessment.

### **Q10: What are the long-term risks associated with Chlordiazepoxide + Imipramine use?**

**A:**  Long-term risks may include tardive dyskinesia (with prolonged imipramine use) and tolerance to the sedative effects of chlordiazepoxide. Regular monitoring and periodic reevaluation of treatment are important.

